End-of-life sedation. Clinical and ethical issues;Sedación al final de la vida: Aspectos clínicos y éticos

Revista Espanola de Geriatria y Gerontologia

Volumn 38, Issue SUPPL. 3, 2003, Pages 44-52

  Porta I Sales, J ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; KETAMINE; LEVOMEPROMAZINE; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; OPIATE; PHENOBARBITAL; PROPOFOL; SCOPOLAMINE; TRANQUILIZER;

CLINICAL FEATURE; DRUG INDICATION; EUTHANASIA; HUMAN; HYPNOSIS; MEDICAL ETHICS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SEDATION;

EID: 1642505611     PISSN: 0211139X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Sibelle Husson M. Le cocktail lytique ou M1. Infokara 1998;51(3):16-21.
2. Billings JA, Block SD. Slow euthanasia. J Palliat Care 1996;12(4):21-30.
3. Azulay A. La doctrina del doble efecto y la eutanasia activa en la práctica de los cuidados paliativos. Med Pal (Madrid) 2001;8(3):113-5.
4. Ventofridda V, Ripamonti C, De Conno F, Tamburini M, Cassielth BR. Symptom prevalence and control during cancer patients' last days of life 1990;6:7-11.
5. Enck RE. Drug-induced terminal sedation for symptom control. Am J Hosp & Palliat Care 1991;8:3-5.
6. De Jonghe B, Cook D, Appere-De-Vecchi C, et al. Using and understanding sedation scoring systems: a systematic review. Intensive Care Med 2000;26:275-85.
7. Porta Sales J. Sedación en Cuidados Paliativos: reflexiones éticas. Acta Bioethica 2000;VI(1):79-87.
8. Morita T, Tsuneto S, Shima Y. Proposed definitions for terminal sedation. Lancet 2001;358:335-6.
9. Process of clinical decision making. En: Randall F, Downie RS, editors. Palliative Care Ethics. 2nd ed. Oxford: Oxford University Press, 1999; p. 103-27.
10. Porta Sales J, Català-Ylla Baré E, Estíbalez Gil A, et al. Estudio multicéntrico catalano-balear sobre sedación terminal en Cuidados Paliativos. Med Pal (Madrid) 1999;6:153-8.
11. Fainsinger RL, Waller A, Bercovici M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-65.
12. Ojeda Martin M, Navarro Marrero A, Gómez Sancho M. Sedación y enfermo oncológico terminal. Med Pal (Madrid) 1997;4(3):101-8.
13. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer. Arch Intern Med 2000;160:786-94.
14. Broeckaert B. Palliative sedation: ethical aspects. En: Between Technology and Humanity: the impactof technology on health care ethics. Leuven: Leuven University Press, 2002; p. 239-55.
15. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994; 10(2):31-8.
16. Porta-Sales J, Nuñez-Olarte JM, Altisent-Trota R, et al. Aspectos éticos de la sedación en Cuidados Paliativos: Trabajos del Comité de Ética de la SECPAL. Med Pal (Madrid) 2002;9:41-6.
17. Chater S, Viola R, Paterson J, et al. Sedation for intractable distress in dying - a survey of experts. Palliat Med 1998;12:255-69.
18. Peruselli C, di Giulio P, Toscani F, et al. Home Palliative Care for terminal cancer patients: a survey on the final week of life. Palliat Med 1999; 13:233-41.
19. Barbero J, Camell H. Sedación y paciente terminal: la conciencia perdida. Med Pal (Madrid) 1997;4:101-7.
20. Couceiro Vidal A, Nuñez Olarte JM. Orientaciones para la sedación del enfermo terminal. Med Pal (Madrid) 2001;8:138-43.
21. Couceira Vidal A. La sedación de los enfermos en el contexto de los cuidados paliativos: análisis desde la ética [en prensa]. Cuadernos de la Fundación Victor Grifols y Lucas.
22. Porta Sales J. Reflexiones éticas en torno a la sedación terminal. Respuesta. Med Pal (Madrid) 2002;9(4):158-9.
23. Ramsay M, Savege T, Simpson B, et al. Controlled sedation with Alphaxalone-Alphadolone. BMJ 1974;2:656-9.
24. Viguria Arrieta J, Rocaford Gil J, Eslava Gurrea E, et al. Sedación con midazolam. Eficacia de un protocolo de tratamiento en pacientes terminales con sintomas no controlables por otros medios. Med Pal (Madrid) 2000;7:2-5.
25. Rivas-Flores J, Vilches-Aguirre Y, Muñoz-Sánchez D, et al. Consentimiento informado en Cuidados Paliativos: Trabajos del Comité de Ética de la SECPAL. Med Pal (Madrid) 2002;9:32-6.
26. Chiu T-Y, Hu W-Y, Lue B-H, et al. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001;21:467-72.
27. Syse A. Norway: valid (as opposed to informed) consent. Lancet 2000;356:1347-8.
28. Maltoni M, Nanni O, Piravano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage 1999;17:240-7.
29. Morita T, Tsunoda J, Inoue S, et al. The palliative prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Suppart Care Cancer 1999;7:128-33.
30. Porta J, Palomar C, March J, et al. Parámetros biológicos y supervivencia en pacientes con neoplasias en situación avanzada y terminal. Med Pal (Madrid) 1994;1(2):31-7.
31. Viganò A, Bruera E, Suarez-Almanzor ME. Terminal cancer syndrome: myth or reality? J Palliat Care 1999;15(4):32-9.
32. Limonero JT, Bayés R, Espaulella J, et al. Grado de precisión del pronóstico de vida en enfermos oncológicos en situación terminal. Med Pal (Madrid) 1994;1:26-30.
33. Oxeham D, Cornbleet MA. Accuracy of prediction of survival by different professional groups in a hospice. Palliat Med 1999;12:117-8.
34. Materstvedt U, Clark D, Ellershaw J, et al. Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force. Palliat Med 2003;17:97-101.
35. Altisent Trota R, Porta Sales J, Rodeles del Pozo R, et al. Declaración sobre la eutanasia de la SECPAL. Med Pal (Madrid) 2002;9:37-40.
36. Matersstvedt U, Kaasa S. Euthanasia and physician - assisted suicide in Scandinavia-with a conceptual suggestion regarding international research in relation to the phenomena. Palliat Med 2002;16:17-32.
37. Porta-Sales J. Sedation and terminal care. Eur J Palliat Care 2001;8(3): 97-100.
38. Stone P, Phillips C, Spruyt O, et al. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997;11:140-4.
39. Fainsinger RL, Waller A, Bercovici M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-65.
40. Breitbart W, Marotta R, Meredith P, et al. Am J Psychiatry 1996; 153:231-7.
41. Bottomley DM, Hanks GW. Subcutaneous midazolam infusion in Palliative Care. J Pain Symptom Manage 1990;5:259-61.
42. Porta J, Palomar C, Ramirez M, et al. La situación agónica: consideraciones sobre su manejo. Med Pal (Madrid) 1994;1 (2):15-24.
43. Johanson GA. Midazolam in terminal care. Am J Hosp & Palliat Care 1993;Jan/Feb:13-4.
44. McNamara P, Minton M, Twycross RG. Use of midazolam in palliative care. Palliat Med 1991;5:244-9.
45. Stirling IC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999;17:363-8.
46. Moyle J. The use of propofol in Palliative Medicine. J Pain Symptom Manage 1995;10:643-6.
47. Ciprés L, Fernández JP, Gómez X, et al. Declaración sobre la atención médica al final de la vida (O.M.C.). Med Pal (Madrid) 2002;9:30-1.
48. Guía de criterios de calidad en cuidados paliativos. Madrid: Ministerio de Sanidad y Consumo, 2002.
49. Fainsinger RL, Miller MJ, Bruera E, et al. Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7(1):5-11.
50. Morita T, Inoue S, Chiara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996;2:32-8.
51. Fainsinger RL, Landman W, Hoskins M, et al. Sedation for uncontrolled symptoms in South African hospice. J Pain Symptom Manage 1998; 16:145-52.
52. Morita T, Tsunoda J, Inoue S, et al. Do hospice clinicians sedate patients intending to hasten death? J Palliat Care 1999;15(3):20-3.
53. Turner K, Chyne R, Aggarwal G, et al. Dignity in dying: a preliminary study of patients in the last three days of life. J Palliat Care 1996;12(2): 7-13.